Neoadjuvant Treatment of Breast Cancer
Condition: Breast Cancer Interventions: Drug: Tamoxifen; Drug: Goserelin; Drug: Letrozole 2.5Mg Tab; Drug: Epirubicin; Drug: cyclophosphamide; Drug: Docetaxel; Drug: paclitaxel; Drug: trastuzumab; Drug: pertuzumab; Drug: Capecitabine Sponsor: National Institute of Oncology, Hungary Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 23, 2021 Category: Research Source Type: clinical trials